What's new

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Mar 14, 2025 - 09:39
 0
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Statement Oliver Zipse, Chairman of the Board of Management of BMW AG, Annual Co...

Next Article

Postpone Interfacial Impoverishment of Zn‐Ions via Neodymium‐Based Conversion Fi...

Related Posts

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Request for advice on the clinical development strategy...

Feb 10, 2025  0

Clinical investigation of medicinal products in the treatment of epileptic disorders - Scientific guideline

Clinical investigation of medicinal products in the tre...

Mar 12, 2025  0